Nakashima S, Kakugawa T, Motomura H, Hirano K, Sasaki E, Nagata Y, et al. Development of imatinibmesylate-induced interstitial lung disease 2 weeks after discontinuation of the treatment: a case report. Multidiscip Respir Med [Internet]. 2012 Nov. 23 [cited 2024 Jul. 7];7. Available from: https://mrmjournal.org/index.php/mrm/article/view/635